As of November 2024 Algernon Pharmaceuticals has 15.15M shares outstanding, a increase of 117.87% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 15.15M | 117.87% |
2022 | 6.95M | -6.51% |
2021 | 7.44M | 76.84% |
2020 | 4.21M | - |